| abstract |
The present invention relates to a benzamide compound of formula (I), or a pharmaceutically acceptable salt thereof:n n n n n n n n Wheren n n R 1 , ring A, n, R 3 and R 4 are as defined in the specification.n n n The present invention is also intended for use as an antiproliferative agent in the prophylaxis or treatment of methods of preparing said compounds, pharmaceutical compositions containing said compounds and tumors, or other proliferative symptoms sensitive to EphB4 and / or EphA2 and / or Src kinase inhibition. It relates to the use of the compound in the manufacture of a medicament for. |